课题基金 / 基金详情

Screening of signal transducing molecules by using transient expression

Screening of signal transducing molecules by using transient expression
利用瞬时表达筛选信号转导分子
批准号:
10557038
负责人:
YOSHIMURA Akihiko
金额:
$7.87万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 1999

项目摘要

项目成果

YOSHIMURA Akihiko的其他基金

相似基金

相关文献

中文摘要
翻译
为了鉴定对增殖或分化至关重要的新型酪氨酸激酶底物,我们开发了一种以活性c-kit为诱饵的双杂交筛选方法。我们克隆了含有SH2结构域和PH结构域的新接头分子APS和STAP-1。RT-POR分析显示,STAP-1在表达c-kit的骨髓细胞组分中表达受限,在CD34-Sca-1+ c-kit +Lin-造血干细胞富集组分中表达最高。小鼠髓系M1高表达STAP-1。然而,在白血病抑制因子诱导M1细胞单核细胞分化时,STAP-1的表达被强烈抑制,这表明STAP-1与未分化的细胞类型有关。在293细胞中,STAP-1被活化的c-kit酪氨酸磷酸化。体外结合实验表明,STAP-1 SH2结构域与c-kit、STAT5等多种酪氨酸磷酸化蛋白相互作用。这些结果表明,在造血干细胞中,STAP-1作为c-kit下游的一个更多的受体分子发挥作用。此外,我们最近克隆了一种新的c-kit或其他酪氨酸激酶底物。这个基因,我们称之为WARS,不包含任何SH2或PH结构域,但具有与果蝇Ras-MAP激酶负调控基因相关的新结构域。我们将试图找出这个基因在癌症发展中的作用。我们克隆了一个新的SH2蛋白JAB,它与JAK2的激酶结构域结合。JAB与JAK酪氨酸激酶相互作用并抑制其活性。通过SH2结构域,JAB与JAK激酶激活环中的磷酸酪氨酸结合并抑制其催化活性。我们已经证明干扰素-γ强烈诱导JAB。我们证明,JAB缺陷小鼠在围产期死亡时淋巴细胞发育发生改变,包括体内活化T细胞的产生。在Rag2或干扰素-γ上消除致死率。背景不足。基于这些结果,我们认为JAB在干扰素-γ的负反馈调控中发挥了重要作用。少
英文摘要
To identify the novel substrate of tyrosine kinases which is important for proliferation or differentiation, we developed a two-hybrid screening using active c-kit as bait. We cloned new adaptor molecules, APS and STAP-1 which contain SH2 domain and PH domain. RT-POR analysis revealed that STAP-1 expression is restricted in bone marrow cell fraction expressing c-kit, and the highest expression was observed in CD34-Sca-1+c-Kit+Lin- hematopoietic stem cell enriched fraction. Murine myeloid cell line, M1 expressed high level of STAP-1. However, the expression was strongly repressed in response to leukemia inhibitory factor which induced monocytic differentiation of M1 cells, suggesting that STAP-1 is associated with undifferentiated cell type. In 293 cells, STAP-1 was tyrosine phosphorylated by activated c-kit. In vitro binding assay suggested that STAP-1 SH2 domain interacted with several tyrosine phosphorylated protein including c-kit and STAT5. These suggest that STAP-1 function as a a … More daptor molecule downstream of c-kit in hematopoietic stem cells.Furthermore, we recently cloned a novel substrate of c-kit or other tyrosine kinases. This gene, we call WARS, does not contain any SH2 or PH domain but has a novel domain related to a gene that is a negative regulator of Ras-MAP kinase in Drosophila. We will try to find the function of this gene in development of cancer.We cloned a novel SH2 protein JAB, that binds to the kinase domain of JAK2. JAB interacts with and inhibits JAK tyrosine kinases. Through the SH2 domain, JAB binds to a phosphotyrosine in the activation loop of the JAK kinases and suppresses their catalytic activity. We have shown that JAB is strongly induced by interferon-γ. We demonstrate that JAB deficient mice die perinatally with altered lymphoid development including the generation of activated T cells in vivo. The lethality is eliminated on a Rag2 or interferon-γ. Deficient background . Based on the results, we propose that JAB plays an essential role in negative feedback regulation of interferon-γ. Less
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
Sasaki A, et al: "Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain."Genes to Cells. 4,6. 339-351 (1999)
Sasaki A 等人:“细胞因子诱导型 SH2 蛋白 3 (CIS3/SOCS3) 通过 N 端激酶抑制区以及 SH2 结构域结合来抑制 Janus 酪氨酸激酶。”基因与细胞。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yasukawa H, et al.: "The JAK-Binding Protein JAB Inhibits Janus Tyrosine Kinase Activity Through Binding in the Activation Loop."EMBO J.. 18, 5. 1309-1320 (1999)
Yasukawa H 等人:“JAK 结合蛋白 JAB 通过与激活环中的结合抑制 Janus 酪氨酸激酶活性。”EMBO J.. 18, 5. 1309-1320 (1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yokouchi M, et al.: "APS, an adaptor protein containing PH and SH2 domains, is associated with the PDGF receptor and c-Cbl and inhibits PDGF-induced mitogenesis"Oncogene. 18・3. 759-767 (1999)
Yokouchi M 等人:“APS 是一种含有 PH 和 SH2 结构域的接头蛋白,与 PDGF 受体和 c-Cbl 相关,并抑制 PDGF 诱导的有丝分裂”Oncogene 18·3 (1999)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tanimura S,et al.: "MDM2 interacts with MDMX through their RING finger domains." FEBS Lett.in press. (1999)
Tanimura S 等人:“MDM2 通过其无名指结构域与 MDMX 相互作用。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 11 条
    Immune systems involved in the resolution of inflammation and tissue repair
    • 批准号:
      17H06175
    • 项目类别:
      Grant-in-Aid for Scientific Research (S)
    • 资助金额:
      $131.71万
    • 财政年份:
      2017
    • 负责人:
      YOSHIMURA Akihiko
    • 依托单位:
    Identification of Cellular Signaling Mechanism that regulates inflammation and tissue repairing
    • 批准号:
      25221305
    • 项目类别:
      Grant-in-Aid for Scientific Research (S)
    • 资助金额:
      $122.8万
    • 财政年份:
      2013
    • 负责人:
      YOSHIMURA Akihiko
    • 依托单位:
    Systemic Biology of T cell differentiation
    • 批准号:
      25670234
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2013
    • 负责人:
      YOSHIMURA Akihiko
    • 依托单位:
    Systembiology of T-cell differentiation
    • 批准号:
      23659242
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      YOSHIMURA Akihiko
    • 依托单位:
    国内基金
    海外基金
    SIRT6通过去乙酰化修饰调控JAK2/STAT1信号通路介导细胞焦亡途径促进脊髓损伤进展的分子机制研究
    • 批准号:
      2026JJ81836
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      陈朝晖
    • 依托单位:
    基于ACO2-JAK/STAT3信号轴探讨芫荽及其活性成分改善动脉粥样硬化的药理机制研究
    • 批准号:
      2026JJ82274
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      侯凯
    • 依托单位:
    黄芪多糖调控JAK2/STAT3信号通路抵抗PD-L1介导的卵巢癌细胞免疫逃逸研究
    益气活血方调控雪旺细胞外泌体/JAK2/STAT3通路介导巨噬细胞极化改善糖尿病足溃疡的作用机制研究
    • 批准号:
      2026JJ80487
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      于洪海
    • 依托单位: